The prospective screening for SARS-CoV-2 S1/S2 antibodies delineates the factual incidence of COVID-19 and shows a sustained serological response post COVID-19 in kidney transplant recipients

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
   PubMed Web of Science ®Google Scholar
• Bouquegneau A, Erpicum P, Grosch S, et al. COVID-19–associated nephropathy includes tubular necrosis and capillary congestion, with evidence of SARS-CoV-2 in the nephron. Kidney360. 2021;2:639–652.
   PubMedGoogle Scholar
• Huart J, Bouquegneau A, Lutteri L, et al. Proteinuria in COVID-19: prevalence, characterization and prognostic role. J Nephrol. 2021;34:355–364.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med. 2007;28:222–242.
   PubMed Web of Science ®Google Scholar
• Firket L, Descy J, Seidel L, et al. Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2. Am J Transplant. 2021;21:3806–3807.
   PubMedGoogle Scholar
• Turbett SE, Anahtar M, Dighe AS, et al. Evaluation of three commercial SARS-CoV-2 Serologic assays and their performance in two-test algorithms. J Clin Microbiol. 2020;59. DOI:10.1128/JCM.01892-20.
   Google Scholar
• Ma Q, Liu J, Liu Q, et al. global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Network Open. 2021;4:e2137257–e2137257.
   PubMed Web of Science ®Google Scholar
• Pinchera B, Spirito L, Ferreri L, et al. SARS-CoV-2 in kidney transplant patients: a real-life experience. Front Med. 2022;9:864865.
   Google Scholar
• Alberici F, Delbarba E, Manenti C, et al. A report from the brescia renal COVID task force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020;98:20.
   PubMed Web of Science ®Google Scholar
• Benotmane I, Perrin P, Vargas GG, et al. Biomarkers of cytokine release syndrome predict disease severity and mortality from COVID-19 in kidney transplant recipients. Transplantation 2021 . 105(1):158–169 .
   Google Scholar
• Bossini N, Alberici F, Delbarba E, et al. Kidney transplant patients with SARS-CoV-2 infection: the brescia renal COVID task force experience. Am J Transplant. 2020;20:3019–3029.
   PubMedGoogle Scholar
• Caillard S, Anglicheau D, Matignon M, et al. An initial report from the French SOT COVID registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int. 2020;98:1549–1558.
   PubMed Web of Science ®Google Scholar
• Crespo M, Mazuecos A, Rodrigo E, et al. Respiratory and gastrointestinal COVID-19 phenotypes in kidney transplant recipients. Transplantation 2020 . 104(11):2225–2233 .
   Web of Science ®Google Scholar
• Demir E, Uyar M, Parmaksiz E, et al. COVID‐19 in kidney transplant recipients: a multicenter experience in Istanbul. Transpl Infect Dis. 2020;22. 10.1111/TID.13371.
   Google Scholar
• Elias M, Pievani D, Randoux C, et al. COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31:2413–2423.
   PubMed Web of Science ®Google Scholar
• Favà A, Cucchiari D, Montero N, et al. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: a multicentric cohort study. Am J Transplant. 2020;20:3030–3041.
   PubMed Web of Science ®Google Scholar
• Sánchez-Álvarez JE, Fontán MP, Martín CJ, et al. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN). Nefrologia. 2020;40:272.
   PubMedGoogle Scholar
• Hadi YB, Naqvi SFZ, Kupec JT, et al. Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network. Transplantation. 2021;105:1365–1371.
   PubMedGoogle Scholar
• Becchetti C, Broekhoven AGC, Dahlqvist G, et al. Humoral response to SARS-CoV-2 infection among liver transplant recipients. Gut. 2022;71:746–756.
   PubMed Web of Science ®Google Scholar
• Burack D, Pereira MR, Tsapepas DS, et al. Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection. Am J Transplant. 2021;21:2254–2261.
   PubMed Web of Science ®Google Scholar
• Chang CC, Vlad G, Vasilescu ER, et al. Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant. Kidney Int. 2021;100:240.
   PubMed Web of Science ®Google Scholar
• Chavarot N, Leruez-Ville M, Scemla A, et al. Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection. Kidney Int. 2021;99:486–488.
   PubMed Web of Science ®Google Scholar
• Prendecki M, Clarke C, Gleeson S, et al. Detection of SARS-CoV-2 antibodies in kidney transplant recipients. J Am Soc Nephrol. 2020;31:2753–2756.
   PubMed Web of Science ®Google Scholar
• Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–1211. 277.
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet. 2020;396:1595–1606.
   PubMed Web of Science ®Google Scholar
• Seow J, Graham C, Merrick B, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nature Microbiology. 2020;5:1598–1607.
   PubMed Web of Science ®Google Scholar
• Benotmane I, Gautier Vargas G, Velay A, et al. Persistence of SARS-CoV-2 antibodies in kidney transplant recipients. Am J Transplant. 2021a;21:2307–2310.
   PubMedGoogle Scholar
• Søfteland JM, Gisslén M, Liljeqvist JA, et al. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls. Am J Transplant. 2022;22:1245–1252.
   PubMed Web of Science ®Google Scholar